1. ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation. (7th January 2021) Authors: Borenäs, Marcus; Umapathy, Ganesh; Lai, Wei‐Yun; Lind, Dan E; Witek, Barbara; Guan, Jikui; Mendoza‐Garcia, Patricia; Masudi, Tafheem; Claeys, Arne; Chuang, Tzu‐Po; El Wakil, Abeer; Arefin, Badrul; Fransson, Susanne; Koster, Jan; Johansson, Mathias; Gaarder, Jennie; Van den Eynden, Jimmy; Hallberg... Journal: EMBO journal Issue: Volume 40:Number 3(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The transcriptomic effects of hyperthermia in cisplatin HIPEC: results from the OVIP trial. Issue 2 (February 2023) Authors: Demuytere, Jesse; Merseburger, Peter; Claeys, Arne; Willaert, Wouter; Van den Eynden, Jimmy; Ceelen, Wim Journal: European journal of surgical oncology Issue: Volume 49:Issue 2(2023) Page Start: e193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗